Trinity Biotech Plc Stock Market Value
| TRIB Stock | USD 1.12 0.01 0.88% |
| Symbol | Trinity |
Trinity Biotech plc Price To Book Ratio
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Trinity Biotech. If investors know Trinity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Trinity Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.77) | Earnings Share (2.25) | Revenue Per Share 6.968 | Quarterly Revenue Growth 0.14 | Return On Assets (0.1) |
The market value of Trinity Biotech plc is measured differently than its book value, which is the value of Trinity that is recorded on the company's balance sheet. Investors also form their own opinion of Trinity Biotech's value that differs from its market value or its book value, called intrinsic value, which is Trinity Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Trinity Biotech's market value can be influenced by many factors that don't directly affect Trinity Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Trinity Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Trinity Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Trinity Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Trinity Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Trinity Biotech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Trinity Biotech.
| 12/08/2022 |
| 11/27/2024 |
If you would invest 0.00 in Trinity Biotech on December 8, 2022 and sell it all today you would earn a total of 0.00 from holding Trinity Biotech plc or generate 0.0% return on investment in Trinity Biotech over 720 days. Trinity Biotech is related to or competes with Star Equity, Standard Biotools, Biodesix, ENDRA Life, Sera Prognostics, Fonar, and Neuronetics. Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laborator... More
Trinity Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Trinity Biotech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Trinity Biotech plc upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 37.82 | |||
| Value At Risk | (9.55) | |||
| Potential Upside | 13.99 |
Trinity Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Trinity Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Trinity Biotech's standard deviation. In reality, there are many statistical measures that can use Trinity Biotech historical prices to predict the future Trinity Biotech's volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.65) | |||
| Total Risk Alpha | (1.74) | |||
| Treynor Ratio | (7.12) |
Trinity Biotech plc Backtested Returns
Trinity Biotech plc owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.11, which indicates the firm had a -0.11% return per unit of risk over the last 3 months. Trinity Biotech plc exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Trinity Biotech's Coefficient Of Variation of (1,117), variance of 49.1, and Risk Adjusted Performance of (0.06) to confirm the risk estimate we provide. The entity has a beta of 0.0895, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Trinity Biotech's returns are expected to increase less than the market. However, during the bear market, the loss of holding Trinity Biotech is expected to be smaller as well. At this point, Trinity Biotech plc has a negative expected return of -0.71%. Please make sure to validate Trinity Biotech's value at risk, as well as the relationship between the accumulation distribution and day typical price , to decide if Trinity Biotech plc performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.54 |
Modest predictability
Trinity Biotech plc has modest predictability. Overlapping area represents the amount of predictability between Trinity Biotech time series from 8th of December 2022 to 3rd of December 2023 and 3rd of December 2023 to 27th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Trinity Biotech plc price movement. The serial correlation of 0.54 indicates that about 54.0% of current Trinity Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.54 | |
| Spearman Rank Test | 0.47 | |
| Residual Average | 0.0 | |
| Price Variance | 0.25 |
Trinity Biotech plc lagged returns against current returns
Autocorrelation, which is Trinity Biotech stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Trinity Biotech's stock expected returns. We can calculate the autocorrelation of Trinity Biotech returns to help us make a trade decision. For example, suppose you find that Trinity Biotech has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Trinity Biotech regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Trinity Biotech stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Trinity Biotech stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Trinity Biotech stock over time.
Current vs Lagged Prices |
| Timeline |
Trinity Biotech Lagged Returns
When evaluating Trinity Biotech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Trinity Biotech stock have on its future price. Trinity Biotech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Trinity Biotech autocorrelation shows the relationship between Trinity Biotech stock current value and its past values and can show if there is a momentum factor associated with investing in Trinity Biotech plc.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Trinity Biotech plc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Trinity Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Trinity Biotech Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Trinity Biotech Plc Stock:Check out Trinity Biotech Correlation, Trinity Biotech Volatility and Trinity Biotech Alpha and Beta module to complement your research on Trinity Biotech. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Trinity Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.